I'm LongbridgeAI, I can summarize articles.In Wednesday's intraday session, XTL Biopharmaceuticals saw a significant gain of 71.7%, reaching $3.95, while Akanda and KalVista Pharmaceuticals rose by 57.63% and 38.79%, respectively. Other notable gainers included Design Therapeutics and First Tracks. Conversely, Sangamo Therapeutics experienced a sharp decline of 39.3%, followed by OSR Holdings and BiomX, which also saw significant losses. Anika Therapeutics and Lexaria Bioscience rounded out the list of losers with declines of 17.17% and 15.94%.
Gainers
- XTL Biopharmaceuticals (NASDAQ:XTLB) stock moved upwards by 71.7% to $3.95 during Wednesday's regular session. The market value of their outstanding shares is at $21.7 million.
- Akanda (NASDAQ:AKAN) shares increased by 57.63% to $27.57. The company's market cap stands at $9.3 million.
- KalVista Pharmaceuticals (NASDAQ:KALV) shares increased by 38.79% to $26.7. The company's market cap stands at $985.5 million.
- Design Therapeutics (NASDAQ:DSGN) stock moved upwards by 30.05% to $16.66. The market value of their outstanding shares is at $799.8 million. The company's, Q1 earnings came out yesterday.
- First Tracks (NASDAQ:TRAX) shares rose 21.17% to $24.3. The market value of their outstanding shares is at $696.7 million.
- GlucoTrack (NASDAQ:GCTK) shares moved upwards by 20.07% to $1.0.
Losers
- Sangamo Therapeutics (NASDAQ:SGMO) stock declined by 39.3% to $0.12 during Wednesday's regular session. The company's market cap stands at $74.7 million.
- OSR Holdings (NASDAQ:OSRH) stock decreased by 32.95% to $0.5. The market value of their outstanding shares is at $19.1 million.
- BiomX (AMEX:PHGE) stock decreased by 20.41% to $0.68. The company's market cap stands at $7.5 million.
- Soligenix (NASDAQ:SNGX) shares fell 18.63% to $0.34. The market value of their outstanding shares is at $4.2 million.
- Anika Therapeutics (NASDAQ:ANIK) shares decreased by 17.17% to $12.64. The market value of their outstanding shares is at $220.0 million. The company's, Q1 earnings came out today.
- Lexaria Bioscience (NASDAQ:LEXX) shares decreased by 15.94% to $0.74. The market value of their outstanding shares is at $21.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock1,019characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.